Role of NRF2 Pathway in Neurodegenerative Diseases A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section “Health Outcomes of Antioxidants and Oxidative
Modulation of Oxidative Stress as aPharmacological Strategy A special issue of Journal of Biological Regulators and Homeostatic Agents. Deadline for manuscript submissions: 30 November 2023 (Status:
Oxidative Stress and NRF2 in Health and Disease A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section “Health Outcomes of Antioxidants and
Crosstalk Between Oxidative Stress and Inflammation in Cardiovascular Diseases, Cancer and Neurodegeneration A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section “Health
Role of the Transcription Factor NRF2 in Neurodegenerative Disorders A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section “Health Outcomes
Role of Nrf2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches II A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
Grant Holder: Universidad Autónoma de Madrid
Start of Action: 19 October, 2021
End of Action: 18 October, 2025
CSO approval date: 25 May 2021
Action email: info@benbedphar.org
© 2022 BenBedPhar | Design by Tuinbit Group
